ÃÛÌÒÊÓÆµ

AbbVie Frees Taxpayers From M&A Capital Loss Limitations

By Mark Melton, Mark Miller and Brad Seltzer ( July 11, 2025, 3:57 PM EDT) -- In a significant win for taxpayers, on June 17 the U.S. Tax Court ruled in AbbVie Inc. v. Commissioner that a $1.6 billion break fee paid by AbbVie qualifies as an ordinary and necessary business expense under Section 162 of the Internal Revenue Code....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login